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Abstract—Ultrasound imaging is a proven diagnostic tool to
assess a myriad of physiological and pathological conditions
in patients. Throughout the years, ultrasounds have been used
as a passive recording modality where the backscattered echo
arising from the interaction of the sound waves with the
acoustic properties of the biological tissues helps to identify
them. Apart from a wide range of therapeutic applications,
the acoustic beam has not yet been explored to actuate within
the biological environment in an active way. In this paper
we present an implantable electronic device to be actuated
remotely by ultrasounds with capabilities for measuring several
physiological parameters of tissues: pH, temperature, electrolyte
concentration and biopotentials. The small factory form device
(with no attached batteries) harvests energy from the incoming
ultrasound waves and uses it to power the embedded electronics.
It operates from voltage levels as low as 0.8 V and consuming
a total current of 60 µA (or an average power consumption
of 84 µW) in the active mode when deployed at a distance of
3 cm from the active source of ultrasounds in vitro, excited
by a sinusoid at 400 kHz with power density of 20 mWcm−2.
The sensor can be actuated by a specifically-designed readout
device (as detailed in this paper) or using the traditional medical
probes for ultrasound imaging. The actual device can present
an alternative to surpass the limitations of inductive and RF-
powered sensors implanted in soft tissues.
I. INTRODUCTION
Ultrasounds (US) have been used for the past decades in
medical imaging to evaluate several physiological processes,
with a particular emphasis on breast cancer scanning, foetal
development assessment in pregnant women and blood flow
measurements [1]. The widespread of ultrasound imaging
as a non-invasive modality for diagnostic and therapeutic
applications has led to the development of a range of ul-
trasound machines with different characteristics and sizes
that are indispensable in the equipment of every major
hospital or clinic. The physics of transdution in US is based
on the piezoelectricity principle found in some materials
that converts mechanical strains into an electric voltage and
vice-versa. The type, size and arrangement of the ultra-
sonic transducer (or array) dictates the operational frequency
(typically between 0.4 - 10 MHz), penetration depth and
apodization of the acoustic beam for the different imaging
modalities offered by US [2]. Although massively used by
clinicians in their practice, the acoustic beams are still to
be explored for purposes other than imaging or therapy in
the medical context, videlicet to operate remotely implanted
sensors within the human body.
The topics of power harvesting and data exchange for
implantable sensors are becoming increasingly popular in the
research community, where competitive (and complementary)
technologies have been proposed in recent years to retrieve
the largest amount of physiological information from patients
while expending the lowest power consumption possible
in the sensor electronics [3]. Energy sources available for
sensors deployed inside a physiological environment include
electrochemical [4], photovoltaic [5], thermoelectric [6],
mechanical [7], magnetic (inductive) [8], electromagnetic
(RF) [9] and ultrasounds [10]. The efficiency in conversion
to readily in-use electrical energy dictates that, for the time
being, only inductive near-field, far-field RF and ultrasounds
have the potential to fulfil the power requirements of the
embedded electronics in the sensor. The major advantages
of employing ultrasonic links is that the power transfer
efficiency can, theoretically, be made higher and the link
is immune to EM interferences caused by the operation of
nearby electronic devices either inside (e.g. pacemakers) or
outside the body (larger ferromagnetic objects).
The area of implantable electronics has already produced
some commercially successful devices like cardiac pace-
makers and defibrillators, neurologic stimulators, drug pump
systems and cochlear implants [11]. The constrains in the
physical dimension and location of these devices, together
with the power consumption requirements, all settle the
framework for achieving the acceptable level of operation of
the implant without causing side effects [12]. The complexity
of the electronics to correctly sense, process and transmit the
data has a direct impact on power consumption which, in
turn, increases the physical volume for energy conversion
and storage [9]. Batteries impose a life-term to the implant
(10 years at best) and a surgical intervention for replacement.
Rechargeable batteries and similar components [13] are
currently being developed to alleviate some geometrical
constrains by means of flexible and stretchable materials
that can really reshape the future of implantable sensor
packaging [14]. However, the need for wireless transmis-
sion of energy to recharge the storage components at the
implant side still remains [15]. Even in the condition of zero-
powering experienced by some passive sensors, there must be
some energy convoy to interrogate and capture the physical
property reflected back by the implant [16]. Both operations
will keep functional as long as the link is active, which might
be sufficient to record the physiological variables of interest.
It is the objective of this paper to describe the electronics
involved in the design of an active implantable sensor and
external readout device using ultrasounds, while providing
some insights into the imaging technique that mediates the
interaction between body tissues and sound waves. Clinical
applications include the evaluation of the physiological state
of a tissue, complementary to the anatomical image produced
by ultrasound imaging, as in the case of assessing local
infections and complications after surgery in soft tissues.
II. MATERIAL AND METHODS
This section details the computational framework devel-
oped to describe the interaction between sound waves and
tissues, where important parameters such as pressure fields
experienced by the implant and acoustic impedance of the
transmission line, can be tested to provide minuteness in the
design of both the implantable sensor and scanning probe.
A. Forward Problem in Ultrasounds
The power delivered to the implantable device depends
on the distribution of the acoustic pressure field generated
by the transmitting piezoelectric transducer and the layers of
biological tissues in the path. The knowledge of the physics
underlying sound wave propagation can help establishing the
preferential location and orientation of the implantable sensor
in the radiated area within safe exposure limits for biolog-
ical tissues (≤ 94 mWcm−2). However, the mathematical
relations involved can hardly be solved in a closed form and
so, numerical approximations are implemented to obtain an
estimation of the fields at stake. Within this approach, the
total field is given by a summation of the incident pressure
field (in the absence of scatterers in the medium) and the
scattered pressure field, in accordance to Expression 1.
ptot(x) = pinc(x) + psct(x) (1)
Further developments over the term psct(x) proceeding
from wave scattering theory [17], helps to re-written the
integral full wave equation as,
ptot(x) = pinc(x) +
∫
x’∈D
G(x− x’)∆γptot(x’)dV+
+
∫
x’∈D
G(x− x’){∇ · [∆ρ∇ptot(x’)]}dV (2)
where ∆γ and ∆ρ are contrast functions that account for the
differences in the complex propagation coefficient γ (atten-
uation) and volume-mass density ρ, respectively; ∇ is the
topological gradient operator whereas ∇· is the divergence;
and G is the Green’s function. The full wave equation just
described can be represented in the form of a linear system by
imposing a forward operator, L, that maps all the topological
relations and properties at any point x in the domain to the
remaining points, as Expression 3 attests.
pinc(x) = L[ptot(x)] (3)
The solution for the equation in terms of the total pressure
field can be solved numerically by resorting to iterative meth-
ods whenever the incident field is known in advance. The
Conjugate Gradient (CG) method approximates the solution
of the field with an iterative step of the form,{
p0 = 0
pn+1 = pn + αnξn
(4)
where p0 is the initial estimate for the total pressure field
(null vector), pn+1 is the updated pressure, αn the step size
and ξn the update direction. The residual field accounting
for the differences from the incident field and normalized
error to control the convergence of CG are both given by
Expression 5. {
rn = p
inc − L[pn]
error = ||rn||D||pinc||D
(5)
Finally, the incident field is pre-computed and stored in
memory before the CG routine takes place, by spatially
convolving the geometrical model of the transducer (source)
with the Green’s function for a background medium as [18],
pinc(x) = ıωρ0
∫
x’∈D
G(x− x’)s(x’)dV (6)
where s(x’) is the source term, ω the angular frequency and
ρ0 the volume-mass density of the background.
Simulations for 2D using a realistic biological phantom
are shown in fig. 1. The domain represents a transversal slice
of the human torso at the level of the third intercostal space
(no blocking bones), with image dimensions of 128 x 64
pixels. All biological tissues are assigned acoustic properties
as found in literature [1], namely density, speed of sound
propagation and attenuation coefficient. The implantable sen-
sor is located in the pericardium of the heart with changing
acoustic properties that will reshape the data transmission
mechanism between the implant and transmitting transducer
in subsequent sections.
B. Electronic Design
1) Implantable Sensor: The first electronic stage directly
connected to the commercial piezoelectric transducer consists
of a voltage doubler interface as illustrated in fig. 2 b).
The transducer can be modelled as a sinusoidal current
source in parallel with an high internal capacitance, C0,
that limits power extraction from the harvester. So it is not
only important to excite the transducer close to its resonant
frequency (400 kHz), but also to employ an inductor in series
to maximize power transfer to the rest of the electronic circuit
(load). When the voltage signal produced is positive for half
Fig. 1. Numerical simulations of the pressure fields in a 2D transversal slice of the human torso, with anatomical contour lines superimposed in red:
a) incident field; b) scattered field obtained when the implant has the same properties as heart muscle; c) scattered field when the implant has different
properties with respect to biological tissues; d) difference in the aforementioned scattered fields that pinpoints the location of the implant (lighter area).
Fig. 2. Simplified diagram of the electronics composing the implantable sensor: a) top and bottom views; b) voltage doubler interface; c) instrumentation
amplifier; d) non-inverting amplifier; e) micro-controller unit with booster circuit; f) temperature-controlled voltage divider; g) inverting amplifier.
the cycle, diode D1 is conducting while D2 is off, charging
capacitor C1; by its turn, in the negative half cycle, the
status of both diodes exchange and C2 is charged. This way,
the interface provides an extra improvement in efficiency
since the voltage delivered to the load, VCC , is twice the
one provided by the four diode-bridge rectifier. Although
the maximum power output is equal for both interfaces, the
simple fact of using just two diodes in the doubler limits the
voltage drop caused by the diode forward voltages (which is
400 mV for the 1N5711).
DC voltage levels stored in the larger capacitor C3 can
peak as high as 10 V in the condition of no load and with the
transducer facing directly the source of the ultrasonic beam.
When loading the circuit, the voltage will drop dramatically
in order to provide for the electric current consumed by
circuit electronics. If one intends to keep a voltage operation
for the sensor around 1 V, a total circuit load of 10 kΩ is
fairly required to keep the discharging time of C3 in the order
of seconds and still accommodating a current of 100 µA.
So, only ultra-low-power components were considered for
the design of the implantable sensor. The choice for the
micro-controller (MCU) fell over the MSP430L092 from
Texas Instruments which exhibits a current consumption of
45 µA with 1 MHz instruction frequency and a voltage range
of operation from 0.8 V to 1.5 V. The only drawback is
the romless nature of the MCU that implies an external
EEPROM to store the 2 kB program code. The MCU is
already equipped with the boot sequence to read data from
an high-speed memory with serial SPI bus capability as long
as signal logics remain at the correct voltage levels. Since
there is still no EEPROM that can operate as low as 1 V, a
voltage booster is required to increase the level of VCC to the
higher value of VDD. The booster topology adapted is shown
in fig. 2 e) which uses the duty-cycle of the PWM signal
produced by the digital pin labelled BOOST and transistor
BC817 to raise VDD to 1.8 V, necessary to transfer the data
from the EEPROM - the M95640 from ST Semiconductors
- to the MCU within a few milliseconds.
The analogue part of the implantable sensor includes four
different modules designed with standard opamp configu-
rations: an inverting amplifier for electrolyte measurements
(lactate/glucose), a non-inverting amplifier for pH measure-
ments, an instrumentation amplifier for biopotential record-
ings and a voltage divider for temperature measurements
(thermistor). The attractive characteristics of the modules
are the employment of an ultra-low-power opamp - the
TS1001 from Silicon Labs - which consumes only 0.6 µA
per amplifier (while operating between 0.5 - 2.5 V) and the
large values set to the resistors in order to limit current
consumption by the circuit. A level of 60 µA is achieved
when all the electronic components (except EEPROM) are
in the active mode of operation.
The voltage levels recorded by each analogue module
are digitalized by the internal ADC of the MCU (8-bit of
resolution) and sampled sequentially within a time period of
10 ms. The data transmission packet includes also two sig-
nalling bytes that convoy a bit-pattern to be recognized by the
external readout device. One digital pin of the MCU is used
to shift-out the bit-pattern using ON-OFF keying modulation
(OOK) directly over the input terminal of the transducer.
Since the ultrasonic beam uses a frequency of 400 kHz to
transmit the energy from outside the body, exciting the same
line with a lower frequency for data transmission does not
compromise the operation of the harvester as long as the line
is de-coupled by a 1N4148 diode, as depicted in the graphic
of fig. 3.
Fig. 3. Temporal recording of the DC level harvested by the sensor (red
line) and voltage signal at the piezoelectric transducer (blue line) with OOK
modulation superimposed over the 400 kHz sine wave. The bit pattern shown
corresponds to 4 bytes: 10100000 10110010 00000000 10100001.
2) Scanning Probe: The external device must be able to
provide energy in the form of ultrasounds to the implantable
sensor at the same time it correctly tracks the data sent by the
latter. The circuit for the scanning probe can be divided into
two modules - ultrasound wave generation and detection -
as illustrated in fig. 4. The micro-controller employed is the
PIC32MZ1024 from Microchip with a cycle frequency of
200 MHz that enables the control of all operations in the
scanning probe, including the routing of the data from the
implantable sensor to a host computer via USB or Bluetooth.
The generation of the ultrasound wave is the responsibility
of a precision timing circuit - the NE555 from Texas Instru-
ments - working in astable mode. The circuit is tuned to
produce a TTL signal with frequency of 400 kHz and 5 V
of amplitude. Further conditioning of the signal by means
of wideband opamps allow to remove the DC component of
the TTL signal, followed by low-pass filtering to eliminate
higher order harmonics (achieving a sinusoid), before split-
ting the wave into two out-of-phase branches that will excite
simultaneously the transducer. The 180◦ phase difference is
achieved by feeding the sine wave to an inverter amplifier
- the OP275 from Analog Devices - with unitary gain and,
then, taking both the input and output signals to produce the
two out-of-phase branches. The piezoelectric element is, this
way, excited by twice the voltage level which yields an higher
pressure field with an intensity close to 20 mWcm−2.
Tracking of the digital data sent by the implantable sensor
is based on the backscaterring process, that is, modulation
of the backscattered ultrasound energy by changing the
electrical impedance of the implantable transducer as seen
by the external circuit. The KLM model of a piezoelectric
transducer defines the resonator as a three-port network with
two acoustic ports and one electrical port [1]. A modification
of the circuit load induced by OOK modulation will change
the acoustic impedance of the implantable transducer which,
in turn, changes the reflectivity of the transmission line
connecting to the readout transducer, quite in a similar
way like the previous numerical simulations have shown.
This change is manifested as a temporal tiny variation on
the amplitude of the out-of-phase voltage signals at the
readout transducer. So, in order to record the variations,
the signals coming from the transducer are first buffered
and amplified before feeding them to a demodulator, built
around the AD633 from Analog Devices. The demodulator
implements the mathematical function of squared differences
as Expression 7 certifies.
VDEM =
(VS1 − VS2)(VS1 − VS2)
10
(7)
In the temporal domain, the operation corresponds to the
multiplication of two sinusoids with the same frequency,
relative similar amplitudes and 180◦ de-phased, yielding an
output signal of the form,
vDEM (t) =
A12
20
∗[cos(180◦)+cos(2∗(2pi∗400×103)+180◦)]
(8)
where the coefficient A12 is the difference in amplitude
between the two sinusoids. Low-pass filtering of vDEM (t)
removes the component corresponding to twice the frequency
of excitation, leaving only the DC term of the signal that
carries the relevant information. The DC value is further
amplified before been digitalised by the MCU with a sam-
pling rate of 10 kSPS and 12-bit of resolution. Whenever the
two signalling bytes within the data transmission packet are
correctly identified by the MCU, the information proceeding
from the implantable sensor is decoded and sent to the
computer.
Fig. 4. Schematics of the scanning probe (readout device) developed for active ultrasound sensing, highlighting the main electronic components involved:
a) top and bottom views; b) Ultrasound wave generation module; c) Backscaterring detection and data transmission module.
III. RESULTS
The implantable sensor was tested in an experimental set-
up consisting, firstly, of a PDMS transmission line connecting
the piezo transducers, followed by the incorporation of a lung
model to mimic a realistic torso phantom, vide fig. 5. PDMS
is a biocompatible material with acoustic properties similar
to biological tissues (namely fat), which can make it a good
candidate for future sensor packaging. PDMS material was
first cooked as a 10 x 10 cm2 sheet with 2 mm of thickness
and then cut into smaller pieces to be stacked together.
Fig. 5. Set-up apparatus developed to test the implantable sensor using a
realistic phantom made of a lung (silicon) and fat tissue (PDMS).
Figures 6 and 7 show the DC level obtained by the
harvester when the implantable sensor moves along the axis
of the acoustic beam and off-axis, respectively, and with
no lung tissue in-between. By its turn, fig. 8 exhibits a
data recording retrieved from the complete phantom for
temperature, biopotential, pH and lactate measurements, the
last ones obtained with electrodes attached to calibrated
laboratory solutions to resemble a physiological environment.
Fig. 6. Voltage level harvested by the implantable sensor as a function of
the distance to the scanning probe transducer, with gap in-between filled by
PDMS material (x-direction).
Fig. 7. Voltage level harvested by the implantable sensor as a function of
the lateral displacement (in the y-direction) of the implantable transducer
relative to the axis of the transmitting one (PDMS gap equal to 1 cm).
Fig. 8. Extended recording obtained for the acquisition channels within
the implantable sensor with the complete phantom (gap = 2 cm). pH is
recorded from calibrated solutions with different values: 6, 4, again 6 and
10. Lactate is obtained from solutions with concentrations 0.5, 4, and 8
mmol/L. Biopotential channel is fed from a waveform function generator,
producing a 20 mV slowly varying sinusoid, while temperature remains
constant during experiments (20◦ C).
IV. CONCLUSION
An implantable sensor to be deployed within a phys-
iological environment has been described with ultrasonic
powering and data transmission capabilities. The device
proved to be fully functional up to 2.5 cm from the scanning
probe, tracking correctly the variations on the physiological
parameters in vitro. The harvested voltage profile obtained
has shown an exponential decay with the distance from the
transmitting transducer and a Gaussian-like shape for off-
axis misalignments between the implantable and transmitting
transducers. The results also demonstrate that the analogue
modules of the sensor can operate up to greater distances
(3.5 cm) when the harvested voltage drops below 0.5 V,
though the MCU is already turned off for these levels. For
the scenario where the sensor is expected to be deployed
even deeper in the body while keeping the data telemetry
functionality, the entire digital part of the sensor can be
replaced by an analogue resonator circuit designed around
the same ultra-low-power opamp employed in this project,
and whose resonant frequency will change according to the
voltage level being recorded, much like in a typical FSK
modulation scheme. Using techniques other than amplitude
modulation to code information helps to compensate for
acoustic signal attenuation produced by biological tissues,
at the expense of requiring a larger bandwidth for data
transmission and a two-level voltage detector (ON-OFF) in
the readout device instead of a full analogue range. However,
the absence of a digital controller might lead to data security
issues since encryption schemes or signalling codes are much
hard to implement in the analogue domain.
Another important improvements to the implantable sensor
include the replacement of the bulky transducers by smaller
ones that are more suitable to conduct in vivo experiments.
The change in dimensions will imply a shift in the operational
frequency that can be easily accommodated by the electronics
developed so far for both the implantable sensor and scanning
probe. The re-design of the circuit board using flexible
substrates is also an option for the implant to conform to the
natural contours of tissues, as in the case of the anastomosis
ring used to reconnect segments in the intestine after surgery.
Regarding power harvesting, advances in MEMS tech-
nology have already produced some ultrasound generators.
However, the nanowatts range achieved is still two orders
of magnitude below the power requirements for electronic
components others than custom-made lab-on-chip sensors.
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